report cover1

CNS Pathologies Market - Global Industry, Analysis, Size, Share, Growth, Trends, and Forecasts 2023-2030

CNS Pathologies is the study of central nervous system diseases. Central nervous system or neurological disorders are very serious problems and major health concerns all over the world. Central nervous system diseases can arise from a complex variety of ischemic, hemorrhagic, neurodegenerative, inflammatory, and development disorders. The multitude of physiological and etiological variables that contribute to such disorders as well as the sensitive nature of the central nervous system itself necessitate diagnostic techniques that provide high specificity and are noninvasive. One of the biggest challenges in the development of therapeutics for central nervous system disorders is achieving sufficient blood-brain barrier penetration. More than 98% of small molecular drugs and nearly 100% of larger molecular therapeutics are ineffective in treating central nervous system diseases since the blood-brain barrier strictly limits the delivery of therapeutic agents to their target site in the central nervous system. Therefore, the development of highly specific surrogate biomarkers for central nervous system diseases will be important in establishing diagnostic and prognostic criteria such as patient subclassification, and reliable therapeutic response assessment as well as contributing to a better understanding of central nervous system pathological features.

Enormous efforts and intensive studies on the discovery of central nervous system disorders are still rare. Therefore, new strategies to increase central nervous system delivery of the currently available therapeutics represent major pharmacological improvements in the treatment of central nervous system disorders. In the last two decades, numerous drug delivery strategies have been investigated to improve the therapeutic effect in brain disorders with varying degrees of success. These strategies range from TJ modulation and drug molecule modification to targeting strategies that are based on endogenous transcytosis and carrier-based transport systems, including nanoparticle and cell-based deliveries.

Global CNS Pathologies Market– Competitive Landscape

On November 20, 2023, Reviva Pharmaceuticals raised USD 30 million for central nervous system drug development. On September 18, 2023, Arilays Therapeutics raised USD 58 million to target autoimmune neuropsychiatric diseases. On March 16, 2023, Noema Pharma raised USD 112 million in series B financing for nervous system disorders. On January 9, 2023, Neurocrine blows fresh wind in Voyager’s sails with USD 175 million upfront for central nervous system capsid collab. On January 4, 2023, Eli Lily is paying USD up front to begin an alliance with Capsida Biotherapeutics pursuing gene therapies for central nervous system disorders. On December 13, 2022, the Dementia discovery fund invested in Amphista Therapeutics as it targets neurodegenerative diseases.

Some of the Key Players in the Global CNS Pathologies Market Include –

  • Biogen
  • Otsuka Pharmaceutical Co. Ltd.
  • Eli Lilly and Company
  • Merck KGaA
  • AstraZeneca
  • Takeda Pharmaceutical Company Limited
  • Novartis AG
  • Teva Pharmaceutical Industries AG

Global CNS Pathologies Market – Growth Drivers

The increasing prevalence of central nervous system disorders, including Alzheimer’s, Parkinson’s, and multiple sclerosis, is a major driver, creating a sustained demand for diagnostics, treatments, and supportive care. According to the National Center for Biotechnology Information (NCBI), the prevalence of neurological disorders from different regions of the country ranged from 967-4,070 with a mean of 2,394 per 100,000 population. The global rise in the aging population contributes significantly to the growth of the central nervous system pathologies market, as age is a key factor in the development of neurological disorders such as Alzheimer’s and Parkinson’s diseases. Continuous advancements in medical imaging technologies, such as MRI and PET scans, enhance early diagnosis and monitoring of central nervous system pathologies, driving growth in the diagnostic segment of the market of central nervous system pathologies. Substantial investments in research and development by pharmaceutical companies, focusing on innovative drug development for various central nervous system development disorders, contribute to the expansion of treatment options and market growth. Ongoing innovations in treatment modalities, including gene therapies, neurostimulation techniques, and precision medicine, provide new avenues for effective intervention, stimulating market growth. Growing awareness and education about mental health and neurological disorders encourage individuals to seek medical attention early contributing to increased diagnosis rates and fueling the demand for central nervous system treatments. The integration of telemedicine and digital health solutions facilitates remote monitoring, consultation, and management of central nervous system disorders, expanding access to healthcare services and supporting market growth.

Global CNS Pathologies Market – Restraints

The stringent regulatory approval processes for central nervous system drugs pose a significant restraint, leading to delays in bringing new treatments to market. The high cost associated with research and development of central nervous system therapies, including clinical trials and preclinical studies, act as a substantial restraint, limiting the ability of some companies to invest in innovative solutions. An incomplete understanding of the underlying mechanism of various central nervous system disorders poses a challenge, hindering the development of targeted and effective treatments. According to the National Center for Biotechnology Information (NCBI), the research and development cost for central nervous system therapies and drugs is estimated at up to USD 1076.9 million. An incomplete understanding of the underlying mechanism of various central nervous system disorders poses a challenge, hindering the development of targeted and effective treatments. The blood-brain barrier presents a significant challenge in drug delivery to the central nervous system, limiting the effectiveness of certain treatments and requiring innovative solutions for drug transport across this barrier. The complexity and heterogeneity of central nervous system disorders make it challenging to develop universal treatments, leading to a fragmented market with specific drugs targeting specific conditions. The potential for adverse events and side effects associated with central nervous system drugs poses a restraint, impacting patient compliance and acceptance of treatments. Disparities in healthcare access, especially in low-income regions, act as a restraint, limiting the availability and affordability of central nervous system treatments for a significant portion of the global population.

Global CNS Pathologies Market – Opportunities

The shift towards personalized medicine creates opportunities to tailor treatments for specific central nervous system disorders, potentially leading to more effective and targeted therapeutic interventions. Ongoing technological advancements in diagnostic tools, such as neuroimaging and biomarker identification, provide opportunities for more accurate and early detection of central nervous system pathologies, enhancing patient outcomes. The expanding pipeline of novel drugs and therapies targeting various central nervous system disorders presents opportunities for pharmaceutical companies to introduce innovative treatments, address unmet medical needs, and diversify the market. Collaboration between pharmaceutical companies, research institutions, and governments on a global scale offers an opportunity for accelerated research and development efforts, leading to the discovery of new treatments and therapies. The increasing adoption of telemedicine and digital health solutions creates opportunities for remote monitoring, diagnosis, and management of central nervous system disorders, improving patient’s accessibility to healthcare services.

Global CNS Pathologies Market – Geographical Insight

The market for global central nervous pathologies is segmented into regions such as North America, Latin America, Europe, Asia-Pacific, the Middle East & Africa. North America is the largest market for global central nervous system pathologies due to the high prevalence of neurological disorders, advanced healthcare infrastructure, and significant investment in research and development. Europe is a key player in the central nervous system market with countries like Germany, the UK, and France contributing significantly. The region benefits from a well-established healthcare system and a growing aging population. The Asia-Pacific region is witnessing an increasing incidence of central nervous system disorders attributed to factors such as population aging, changing lifestyles, and improved awareness. Countries like China and Japan are pivotal in shaping the regional market.

Global CNS Pathologies Market – Key Development

  • On August 4, 2023, the FDA approved ZURZUVAR™, the first and only oral treatment approved for women with postpartum depression, and issued a complete response letter for major depressive disorder.
  • On May 19, 2023, Dyno Therapeutics launched the Dyno bCap 1™ capsid product, a breakthrough central nervous system gene delivery vector created with generative artificial intelligence.
  • On January 27, 2023, the U.S. FDA approved Jaypirca™, the first and only non-covalent BTK inhibitor, for adult patients with relapsed or refractory mantle cell lymphoma after at least two lines of systemic therapy.
  • On August 9, 2022, launched of first WHO position paper on optimizing brain health across life.


Complete the form below and we'll get back to you shortly
Table of Content
Complete the form below and we'll get back to you shortly

Research Methodology: Aspects

Market research is a crucial tool for organizations aiming to navigate the dynamic landscape of customer preferences, business trends, and competitive landscapes. At Cognizance Market Research, acknowledging the importance of robust research methodologies is vital to delivering actionable insights to our clientele. The significance of such methodologies lies in their capability to offer clarity in complexity, guiding strategic management with realistic evidence rather than speculation. Our clientele seek insights that excel superficial observations, reaching deep into the details of consumer behaviours, market dynamics, and evolving opportunities. These insights serve as the basis upon which businesses craft tailored approaches, optimize product offerings, and gain a competitive edge in an ever-growing marketplace.

The frequency of information updates is a cornerstone of our commitment to providing timely, relevant, and accurate insights. Cognizance Market Research adheres to a rigorous schedule of data collection, analysis, and distribution to ensure that our reports reflect the most current market realities. This proactive approach enables our clients to stay ahead of the curve, capitalize on emerging trends, and mitigate risks associated with outdated information.

Our research process is characterized by meticulous attention to detail and methodological rigor. It begins with a comprehensive understanding of client objectives, industry dynamics, and research scope. Leveraging a combination of primary and secondary research methodologies, we gather data from diverse sources including surveys, interviews, industry reports, and proprietary databases. Rigorous data analysis techniques are then employed to derive meaningful insights, identify patterns, and uncover actionable recommendations. Throughout the process, we remain vigilant in upholding the highest standards of data integrity, ensuring that our findings are robust, reliable, and actionable.

Key phases involved in in our research process are mentioned below:


Understanding Clients’ Objectives:

Extensive Discussions and Consultations:

  • We initiate in-depth discussions and consultations with our clients to gain a comprehensive understanding of their objectives. This involves actively listening to their needs, concerns, and aspirations regarding the research project.
  • Through these interactions, we aim to uncover the underlying motivations driving their research requirements and the specific outcomes they hope to achieve.

Industry and Market Segment Analysis:

  • We invest time and effort in comprehensively understanding our clients’ industry and market segment. This involves conducting thorough research into market trends, competitive dynamics, regulatory frameworks, and emerging opportunities or threats.
  • By acquiring a deep understanding of the broader industry landscape, we can provide context-rich insights that resonate with our clients’ strategic objectives.

Target Audience Understanding:

  • We analyze our clients’ target audience demographics, behaviors, preferences, and needs to align our research efforts with their consumer-centric objectives. This entails segmenting the audience based on various criteria such as age, gender, income level, geographic location, and psychographic factors.
  • By understanding the nuances of the target audience, we can tailor our research methodologies to gather relevant data that illuminates consumer perceptions, attitudes, and purchase intent.


Identifying Challenges and Opportunities:

  • We proactively identify the challenges and opportunities facing our clients within their respective industries. This involves conducting SWOT (Strengths, Weaknesses, Opportunities, Threats) analyses and competitive benchmarking exercises.
  • By identifying potential obstacles and growth drivers, we can provide strategic recommendations that help our clients navigate complexities and capitalize on emerging opportunities effectively.

Grasping Specific Goals:

  • We delve into the intricacies of our clients’ objectives to gain clarity on the specific goals they aim to accomplish through the research. This entails understanding their desired outcomes, such as market expansion, product development, or competitive analysis.
  • By gaining a nuanced understanding of our clients’ goals, we can tailor our research approach to address their unique challenges and opportunities effectively.

Data Collection:


Primary Research Process:

  • Surveys: We design and administer surveys tailored to capture specific information relevant to our clients’ objectives. This may involve employing various survey methodologies, such as online, telephone, or face-to-face interviews, to reach target audiences effectively.
  • Interviews: We conduct structured or semi-structured interviews with key stakeholders, industry experts, or target consumers to gather in-depth insights and perspectives on relevant topics. These interviews allow us to probe deeper into specific issues and uncover valuable qualitative data.
  • Focus Groups: We organize focus group discussions with carefully selected participants to facilitate interactive discussions and gather collective opinions, attitudes, and preferences. This qualitative research method provides rich contextual insights into consumer behaviors and perceptions.
  • Observations: We conduct observational research by directly observing consumer behaviors, interactions, and experiences in real-world settings. This method enables us to gather objective data on consumer actions and reactions without relying on self-reported information.

Secondary Research Process:

  • Literature Review: We conduct comprehensive literature reviews to identify existing studies, academic articles, and industry reports relevant to the research topic. This helps us gain insights into previous research findings, theoretical frameworks, and best practices.
  • Industry Reports: We analyze industry reports published by reputable trade associations (whitepapers, research studies, etc.), and government agencies (U.S. Census Bureau, Bureau of Labor Statistics, and Securities and Exchange Commission etc.) to obtain macro-level insights into market trends, competitive landscapes, and industry dynamics.
  • Government Publications: We review government publications, such as economic reports, regulatory documents, and statistical databases, to gather relevant data on demographics, market size, consumer spending patterns, and regulatory frameworks.
  • Online Databases: We leverage online databases, such as industry portals, and academic repositories (PubMed Central (PMC), ScienceDirect, SSRN (Social Science Research Network), Directory of Open Access Journals (DOAJ), NCBI, etc.), to access a wide range of secondary data sources, including market statistics, financial data, and industry analyses.



Data Analysis:

The data analysis phase serves as a critical juncture where raw data is transformed into actionable insights that inform strategic decision-making. Through the utilization of analytical methods such as statistical analysis and qualitative techniques like thematic coding, we uncover patterns, correlations, and trends within the data. By ensuring the integrity and validity of our findings, we strive to provide clients with accurate and reliable insights that accurately reflect the realities of the market landscape.


Transformation of Raw Data:

  • Upon collecting the necessary data, we transition into the data analysis phase, where raw data is processed and transformed into actionable insights. This involves organizing, cleaning, and structuring the data to prepare it for analysis.

Utilization of Analytical Methods:

  • Depending on the research objectives, we employ a diverse range of analytical methods to extract meaningful insights from the data. These methods include statistical analysis, trend analysis, regression analysis, and qualitative coding.

Statistical Analysis:

  • Statistical tools are instrumental in uncovering patterns, correlations, and trends within the data. By applying statistical techniques such as descriptive statistics, hypothesis testing, and multivariate analysis, we can discern relationships and derive valuable insights.

Qualitative Analysis Techniques:

  • In addition to quantitative analysis, we leverage qualitative analysis techniques to gain deeper insights from qualitative data sources such as interviews or open-ended survey responses. One such technique is thematic coding, which involves systematically categorizing and interpreting themes or patterns within qualitative data.

Integrity and Validity Maintenance:

  • Throughout the analysis process, we maintain a steadfast commitment to upholding the integrity and validity of our findings. This entails rigorous adherence to established methodologies, transparency in data handling, and thorough validation of analytical outcomes.

Data Validation:

The final phase of our research methodology is data validation, which is essential for ensuring the reliability and credibility of our findings. Validation involves scrutinizing the collected data to identify any inconsistencies, errors, or biases that may have crept in during the research process. We employ various validation techniques, including cross-referencing data from multiple sources, conducting validity checks on survey instruments, and seeking feedback from independent experts or peer reviewers. Additionally, we leverage internal quality assurance protocols to verify the accuracy and integrity of our analysis. By subjecting our findings to rigorous validation procedures, we instill confidence in our clients that the insights they receive are robust, reliable, and trustworthy.


Importance of Data Validation:

  • Data validation is the final phase of the research methodology, crucial for ensuring the reliability and credibility of the findings. It involves a systematic process of reviewing and verifying the collected data to detect any inconsistencies, errors, or biases.

Scrutiny of Collected Data:

  • The validation process begins with a thorough scrutiny of the collected data to identify any discrepancies or anomalies. This entails comparing data points, checking for outliers, and verifying the accuracy of data entries against the original sources.

Validation Techniques:

  • Various validation techniques are employed to ensure the accuracy and integrity of the data. These include cross-referencing data from multiple sources to corroborate findings, conducting validity checks on survey instruments to assess the reliability of responses, and seeking feedback from independent experts or peer reviewers to validate the interpretation of results.

Internal Quality Assurance Protocols:

  • In addition to external validation measures, internal quality assurance protocols are implemented to further validate the accuracy of the analysis. This may involve conducting internal audits, peer reviews, or data validation checks to ensure that the research process adheres to established standards and guidelines.
- Get Started -

Get insights that lead to new growth opportunities

Need a Custom Report?

We can customize every report – free of charge – including purchasing stand-alone sections or country-level reports

Want to Buy a Report but have a Limited Budget?

We help clients to procure the report or sections of the report at their budgeted price. Kindly click on the below to avail

Business Development

small c popup.png
Buy Now
small c popup.png
Complete the form below and we'll get back to you shortly
small c popup.png
Complete the form below and we'll get back to you shortly
small c popup.png
Complete the form below and we'll get back to you shortly
Ask an Expert